Re: Bypassing the iceberg....Warning, stream on consciousness post
|
7
|
Resverlogix Corp.
|
Feb 10, 2016 04:25PM
|
Re: Bypassing the iceberg....Warning, stream on consciousness post
|
4
|
Resverlogix Corp.
|
Feb 11, 2016 09:05AM
|
Re: CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.
|
5
|
Resverlogix Corp.
|
Mar 05, 2023 11:36AM
|
Re: Can we seek funding for this?
|
6
|
Resverlogix Corp.
|
Oct 04, 2023 08:42AM
|
Re: Cancer research derailed by nearly two years due to COVID-19, scientists say.
|
5
|
Zenith Epigenetics
|
Apr 26, 2021 05:58PM
|
Re: Carotid stenosis study
|
5
|
Resverlogix Corp.
|
Feb 26, 2020 05:49PM
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
5
|
Resverlogix Corp.
|
Jan 05, 2022 11:55AM
|
Re: Cash burn and the cost of servicing the loan....
|
4
|
Resverlogix Corp.
|
Apr 16, 2018 12:42PM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
4
|
Zenith Epigenetics
|
Jan 30, 2019 07:36AM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
5
|
Zenith Epigenetics
|
Jan 30, 2019 10:14AM
|
Re: Chart indicates a return to ~$3.77 near term imo...cup or bowl pattern
|
4
|
Resverlogix Corp.
|
Sep 04, 2018 04:27PM
|
Re: Checklist to Management
|
5
|
Resverlogix Corp.
|
Jul 30, 2016 11:46AM
|
Re: Checklist to Management
|
2
|
Resverlogix Corp.
|
Jul 30, 2016 01:15PM
|
Re: China- 1 Million daily COVID cases
|
4
|
Resverlogix Corp.
|
Dec 27, 2022 11:56AM
|
Re: Clayton answered my email....
|
3
|
Resverlogix Corp.
|
Jul 28, 2017 10:02PM
|
Re: Clinicaltrials.gov
|
4
|
Zenith Epigenetics
|
May 13, 2018 03:15PM
|
Re: Closing thoughts on 2015...Why its so hard to buy low
|
7
|
Resverlogix Corp.
|
Jan 01, 2016 12:35PM
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 03, 2021 03:52PM
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 09, 2019 09:36AM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
5
|
Resverlogix Corp.
|
Jun 02, 2022 03:00PM
|